Galectin Therapeutics Inc. Common Stock
NASDAQ · GALT
Fundamentals
Market cap
$354.99M
Price / Earnings ratio
-12.7x
Price / Sales ratio
N/A
Price / Book ratio
-2.6x
Return on assets
-1.7%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A


